Skip to content

Corvel CRVL Accrued liabilities

Accrued liabilities at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
$72M+112%

Other financials

Income statement

See full
Revenue$248.5M+7.4%
Gross profit$63.0M+8.3%
Net income$31.0M+17.4%
EPS (diluted)$0.61+19.6%

Balance sheet

See full
Cash & equivalents$233.1M+36.6%
Total debt$28.1M+0.1%
Total equity$394.2M+22.4%
Total assets$643.0M+17.8%

Cash flow

See full
Operating cash flow$29.5M+28.6%
CapEx$9.2M+5.9%
Free cash flow$20.3M+42.3%

Valuation

See full
Market cap$3.03B-51.4%
Enterprise value$2.82B-53.8%
P/E27.4×-38.0×
P/S3.2×-3.8×

Profitability

See full
Gross margin24.3%+0.9pp
Net margin11.5%+0.9pp
FCF margin11.5%+1.3pp

Returns & leverage

See full
Return on equity30.8%-2.6pp
Debt / equity0.1×0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Corvel’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvel's accrued liabilities?
Corvel (CRVL) reported accrued liabilities of $13.23M in Q4 2025.
How has Corvel's accrued liabilities changed year-over-year?
Corvel's accrued liabilities increased by 829.7% year-over-year, from $1.42M to $13.23M.